Corporate profile

Science for a better life - Medical Progress for the Benefit of the Patient

Bayer Schering Pharma is one of the ten largest specialty pharmaceutical companies in the world and the company's goal is a leading market position in each of its specialist fields. With its distinctive expertise in research, the company develops new medicines and therapies which make an essential contribution toward improving patient's quality of life.

Our outstanding research activities, together with our highly motivated staff, secure the sustainable success and growth of our company. We focus on four business areas, in which we make essential contributions to medical progress:

  • Diagnostic Imaging
  • General Medicine
  • Specialty Medicine
  • Women’s Healthcare

Facts and Figures

Established:In 2006 Bayer AG acquired Schering AG, Germany, to combine its pharmaceutical business with Schering AG's business.
Headquarter:Berlin
Headcount:Approx. 37,000 members of staff worldwide (Full time equivalents as of December 31, 2007.)
Sales in 2007:EUR 10.267 billion
Main research locations: Berlin and Wuppertal in Germany; Berkeley, USA.
Production locations: Europe, United States, Latin America and Asia.
Subsidiaries:The company has subsidiaries in over 100 countries worldwide.

Main R&D fields

LocationMain field
Berlin:Diagnostic Imaging, Oncology and Women's Healthcare
Wuppertal:Hematology, Cardiology and Oncology
Berkeley:Biologics

Search
Font size
- 1 2 3 + Font size

click to adjust

Page tools
Your opinion counts

http://www.bonefos.com/scripts/pages/en/company/about_us/corporate_profile/index.php

Copyright © Bayer Schering Pharma AG